| GTO ID | GTC3392 |
| Trial ID | NCT05800405 |
| Disease | Diffuse Large B-Cell Lymphoma |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Co-treatment | External Beam Radiation Therapy |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | A Feasibility Study of Bridging Radiation to All Sites of FDG-Avid Disease for Commercial CAR T-Cell Infusion in Patients With Large B-Cell Lymphoma |
| Year | 2023 |
| Country | United States |
| Company sponsor | City of Hope Medical Center |
| Other ID(s) | 22141|NCI-2023-02190|22141|P30CA033572 |
| Cohort 1 | |||||||
|
|||||||